Subscribe To
Betterlife pharma says new study of lsd validates the cognitive effects of its analog drug betr-001
A recent study of the nootropic effects of LSD, published in the scientific journal Experimental Neurology, is validating for BetterLife Pharma Inc (C...
August 24, 2022, 9:10 am
Eisai to present the latest lecanemab data, including aria-e and subcutaneous formulation, and other alzheimer's disease research at the alzheimer's association international conference (aaic) 2022
TOKYO , July 25, 2022 /PRNewswire/ -- Eisai Co. Ltd (Headquarters: Toyoko, CEO: Haruo Naito, "Eisai") announced today that the company will present re...
July 25, 2022, 7:32 pm
Hoth therapeutics shares surge on encouraging preclinical data from alzheimer's program
Hoth Therapeutics Inc (NASDAQ: HOTH) has announced proof-of-concept data generated using cognitive a...
July 12, 2022, 2:37 pm
Why hoth therapeutics shares are skyrocketing today
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher by 17% to $0.47 Tuesday morning after the company announced its HT-ALZ therapeutic sh...
July 12, 2022, 11:42 am
Roche (rhhby) alzheimer's disease drug data disappoints
Roche's (RHHBY) study evaluating crenezumab in autosomal dominant Alzheimer's disease did not slow or prevent ...
June 16, 2022, 1:52 pm
Roche-ac immune's crenezumab fails to show benefit in sub-set of alzheimer's patients
Roche Holdings AG (OTC: RHHBY) said its Alzheimer's medicine crenezumab did not slow or prevent cognitive...
June 16, 2022, 8:36 am
Ac immune shares slide 15% premarket after trial of alzheimer's treatment misses its main goals
Shares of biotech AC Immune SA ACIU, -9.21% slid 15% in premarket trade Thursday, after the company said a a trial of a treatment for Alzheimer's dise...
June 16, 2022, 6:39 am
Havn life to present at upcoming ld micro invitational xii
CEO, Tim Moore will share recent partnership and distribution news and a roadmap for the Company's plans for the next quarterVancouver, British Columb...
June 6, 2022, 11:38 am
Synaptogenix to present at sachs 5th annual neuroscience innovation forum
NEW YORK , March 22, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company ...
March 22, 2022, 9:15 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Can improved cloud & cognitive software drive ibm q4 earnings?
In the fourth quarter, IBM is likely to have recorded higher year-over-year revenues from the Cloud & cognitiv...
January 20, 2022, 9:59 am
Can improved cloud & cognitive software drive ibm q4 earnings?
In the fourth quarter, IBM is likely to have recorded higher year-over-year revenues from the Cloud & cognitiv...
January 20, 2022, 9:59 am
Can improved cloud & cognitive software drive ibm q4 earnings?
In the fourth quarter, IBM is likely to have recorded higher year-over-year revenues from the Cloud & cognitiv...
January 20, 2022, 9:59 am